The Lancet1 小时
Overcoming the challenges of overtreating and undertreating inflammatory bowel disease
Several therapeutic advances have been achieved over the past two decades for inflammatory bowel disease (IBD). The expanding ...
The Lancet41 分钟
First phase 3 trial of GLP-1 receptor agonist for neurodegeneration
The discovery and development of GLP-1 receptor agonists for type 2 diabetes and obesity is a bench-to-bedside success story.1 Multiple GLP-1 receptor agonists are now in clinical use, such as ...
The Lancet23 小时
Bullous Wells syndrome in a patient with occult nasopharyngeal carcinoma
A 58-year-old male patient presented to the dermatology clinic at West China Hospital of Sichuan University (Chengdu, Sichuan ...
The Lancet23 小时
Aromatase inhibitors, cardiovascular medications, and patient outcomes
We read with interest the article by Marie Lund and colleagues published in The Lancet Oncology investigating the association ...
The Lancet23 小时
Fires and their smouldering health effects
In January, 2025, six wildfires broke out and spread rapidly across the greater Los Angeles region in California, USA. Fanned by the strong Santa Ana winds, these raging infernos have caused ...